Shares of Sight Sciences, Inc. (NASDAQ:SGHT – Get Rating) have been given an average rating of “Moderate Buy” by the seven research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 […]
Sight Sciences (NASDAQ:SGHT – Get Rating) had its price target cut by Bank of America from $13.00 to $10.00 in a research report report published on Tuesday, The Fly reports. Sight Sciences Trading Down 1.8 % Shares of Sight Sciences stock opened at $7.81 on Tuesday. The firm has a 50-day simple moving average of […]
Sight Sciences (NASDAQ:SGHT – Get Rating) had its price target reduced by Bank of America from $13.00 to $10.00 in a research note published on Tuesday, The Fly reports. Sight Sciences Stock Down 0.5 % SGHT opened at $7.95 on Tuesday. Sight Sciences has a fifty-two week low of $5.35 and a fifty-two week high […]
Sight Sciences (NASDAQ:SGHT – Get Rating) and NEXGEL (NASDAQ:NXGL – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations. Institutional & Insider Ownership 50.2% of Sight Sciences shares are […]
Jackson Square Partners LLC lifted its stake in shares of Sight Sciences, Inc. (NASDAQ:SGHT – Get Rating) by 43.4% during the fourth quarter, Holdings Channel reports. The firm owned 1,209,704 shares of the company’s stock after purchasing an additional 366,093 shares during the quarter. Jackson Square Partners LLC’s holdings in Sight Sciences were worth $14,770,000 […]